Search

everythinglearnresearchcommunity

for

Search:↓

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Pantethine may boost the immune system's ability to fight sarcoma.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Diuretics can cause serious side effects and should be used carefully.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Physical activity, height, and smoking affect prostate cancer risk.

More research is needed to find effective treatments for sickle cell disease-related priapism.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

PCOS may increase the risk of certain cancers.

Lower LDL-c levels predict higher COVID-19 mortality.

Social media data can help track and predict COVID-19 symptoms and trends.

High TSPEAR levels in colorectal cancer predict worse outcomes.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Different medications can cause serious side effects in some people.

The model and estimator can predict drug exposure in kidney transplant patients well.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.